Garde Capital Inc. lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 7.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 943 shares of the healthcare conglomerate’s stock after buying an additional 66 shares during the period. Garde Capital Inc.’s holdings in UnitedHealth Group were worth $500,000 as of its most recent SEC filing.
Several other hedge funds also recently modified their holdings of the business. Chelsea Counsel Co. acquired a new position in UnitedHealth Group in the 4th quarter valued at $27,000. Freedom Wealth Alliance LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at $31,000. Investors Research Corp grew its stake in UnitedHealth Group by 51.1% in the 4th quarter. Investors Research Corp now owns 71 shares of the healthcare conglomerate’s stock valued at $38,000 after buying an additional 24 shares during the last quarter. Legend Financial Advisors Inc. acquired a new position in UnitedHealth Group in the 3rd quarter valued at $37,000. Finally, Bourgeon Capital Management LLC grew its stake in UnitedHealth Group by 192.3% in the 4th quarter. Bourgeon Capital Management LLC now owns 76 shares of the healthcare conglomerate’s stock valued at $40,000 after buying an additional 50 shares during the last quarter. Institutional investors and hedge funds own 86.31% of the company’s stock.
Insider Transactions at UnitedHealth Group
In other news, CEO Andrew Witty sold 6,160 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, April 27th. The shares were sold at an average price of $487.49, for a total transaction of $3,002,938.40. Following the completion of the sale, the chief executive officer now owns 86,564 shares in the company, valued at approximately $42,199,084.36. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, EVP Erin Mcsweeney sold 1,684 shares of UnitedHealth Group stock in a transaction that occurred on Monday, April 24th. The shares were sold at an average price of $488.46, for a total transaction of $822,566.64. Following the transaction, the executive vice president now owns 8,675 shares of the company’s stock, valued at approximately $4,237,390.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Andrew Witty sold 6,160 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total transaction of $3,002,938.40. Following the transaction, the chief executive officer now directly owns 86,564 shares in the company, valued at approximately $42,199,084.36. The disclosure for this sale can be found here. Insiders sold a total of 8,852 shares of company stock worth $4,313,962 in the last quarter. 0.35% of the stock is owned by company insiders.
Analysts Set New Price Targets
A number of analysts have weighed in on the stock. Piper Sandler assumed coverage on shares of UnitedHealth Group in a report on Thursday, May 25th. They issued an “overweight” rating and a $580.00 price target for the company. Cantor Fitzgerald assumed coverage on shares of UnitedHealth Group in a report on Thursday, April 20th. They issued an “overweight” rating and a $591.00 price target for the company. Deutsche Bank Aktiengesellschaft reduced their price target on shares of UnitedHealth Group from $627.00 to $564.00 in a report on Friday. Oppenheimer reaffirmed an “outperform” rating and set a $610.00 price objective on shares of UnitedHealth Group in a report on Monday, April 17th. Finally, Stephens reaffirmed an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a report on Tuesday, February 28th. One investment analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $592.68.
UnitedHealth Group Trading Down 1.6 %
UNH opened at $458.39 on Friday. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $426.77 billion, a PE ratio of 20.96, a PEG ratio of 1.34 and a beta of 0.68. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $558.10. The firm has a 50-day moving average price of $489.88 and a two-hundred day moving average price of $494.88.
UnitedHealth Group (NYSE:UNH – Get Rating) last posted its quarterly earnings data on Friday, April 14th. The healthcare conglomerate reported $6.26 earnings per share for the quarter, beating the consensus estimate of $6.24 by $0.02. The firm had revenue of $91.93 billion during the quarter, compared to analysts’ expectations of $89.77 billion. UnitedHealth Group had a net margin of 6.16% and a return on equity of 27.05%. The company’s quarterly revenue was up 14.7% compared to the same quarter last year. During the same quarter last year, the company posted $5.49 EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 24.9 earnings per share for the current fiscal year.
UnitedHealth Group Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 27th. Stockholders of record on Monday, June 19th will be given a dividend of $1.88 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.65. The ex-dividend date is Thursday, June 15th. This represents a $7.52 annualized dividend and a dividend yield of 1.64%. UnitedHealth Group’s payout ratio is currently 30.18%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Get Rating).
Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.